Crocetin induces cytotoxicity and enhances vincristine-induced cancer cell death via p53-dependent and -independent mechanisms

Acta Pharmacologica Sinica

Volumn 32, Issue 12, 2011, Pages 1529-1536

  Zhong, Ying Jia ^a,b   Shi, Fang ^a   Zheng, Xue Lian ^a   Wang, Qiong ^a   Yang, Lan ^a   Sun, Hong ^a   He, Fan ^a   Zhang, Lin ^a   Lin, Yong ^a   Qin, Yong ^b   Liao, Lin Chuan ^b   Wang, Xia ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

apoptosis; cell cycle; crocetin; neoplasm; p53; vincristine

Indexed keywords

CROCETIN; PROPIDIUM IODIDE; PROTEIN P21; PROTEIN P53; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL PROLIFERATION; CELL STRAIN A549; CELL STRAIN SKOV3; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LUNG NON SMALL CELL CANCER; OVARY CANCER; UTERINE CERVIX CANCER; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAROTENOIDS; CELL LINE, TUMOR; DRUG SYNERGISM; FLOW CYTOMETRY; HUMANS; TUMOR SUPPRESSOR PROTEIN P53; VINCRISTINE;

EID: 82955201782     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.109     Document Type: Article

References (29)

1. Ordoudi SA, Befani CD, Nenadis N, Koliakos GG, Tsimidou MZ. Further examination of antiradical properties of Crocus sativus stigmas extract rich in crocins. J Agric Food Chem 2009; 57: 3080-6.
2. Kanakis CD, Tarantilis PA, Pappas C, Bariyanga J, Tajmir-Riahi HA, Polissiou MG. An overview of structural features of DNA and RNA complexes with saffron compounds: Models and antioxidant activity. J Photochem Photobiol 2009; 95: 204-12.
3. Lee IA, Lee JH, Baek NI, Kim DH. Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite Crocetin. Biol Pharm Bull 2005; 28: 2106-10. (Pubitemid 41634260)
4. Zheng S, Qian Z, Tang F, Sheng L. Suppression of vascular cell adhesion molecule-1 expression by crocetin contributes to attenuation of atherosclerosis in hypercholesterolemic rabbits. Biochem Pharmacol 2005; 70: 1192-9. (Pubitemid 41317513)
5. He SY, Qian ZY, Wen N, Tang FT, Xu GL, Zhou CH. Influence of Crocetin on experimental atherosclerosis in hyperlipidamic-diet quails. Eur J Pharmacol 2007; 554: 191-5. (Pubitemid 44879406)
6. Cai J, Yi FF, Bian ZY, et al. Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway. J Cell Mol Med 2009; 13: 909-25.
7. Dhar A, Cherian G, Dhar G, Ray G, Sharma R, Banerjee SK. Molecular basis of protective effect by crocetin on survival and liver tissue damage following hemorrhagic shock. Mol Cell Biochem 2005; 278: 139-46. (Pubitemid 41418929)
8. Ahmad AS, Ansari MA, Ahmad M, Saleem S, Yousuf S, Hoda MN, et al. Neuroprotection by crocetin in a hemi-parkinsonian rat model. Pharmacology, biochemistry, and behavior 2005; 81: 805-13. (Pubitemid 41187813)
9. Giaccio M. Crocetin from saffron: an active component of an ancient spice. Crit Rev Food Sci Nutr 2004; 44: 155-72. (Pubitemid 38732378)
10. Jagadeeswaran R, Thirunavukkarasu C, Gunasekaran P, Ramamurty N, Sakthisekaran D. In vitro studies on the selective cytotoxic effect of crocetin and quercetin. Fitoterapia 2000; 71: 395-9. (Pubitemid 30488151)
11. Dhar A, Mehta S, Dhar G, Dhar K, Banerjee S, Van Veldhuizen P, et al. Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model. Mol Cancer Ther 2009; 8: 315-23.
12. Chryssanthi DG, Lamari FN, Iatrou G, Pylara A, Karamanos NK, Cordopatis P. Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. Anticancer Res 2007; 27: 357-62. (Pubitemid 46363354)
13. Wang CJ, Lee MJ, Chang MC, Lin JK. Inhibition of tumor promotion in benzo[a]pyrene-initiated CD-1 mouse skin by crocetin. Carcinogenesis 1995; 16: 187-91.
14. Magesh V, DurgaBhavani K, Senthilnathan P, Rajendran P, Sakthisekaran D. In vivo protective effect of crocetin on benzo(a) pyrene-induced lung cancer in Swiss albino mice. Phytother Res 2009; 23: 533-9.
15. Chen W, Wang X, Bai L, Liang X, Zhuang J, Lin Y. Blockage of NFkappaB by IKKbeta- or RelA-siRNA rather than the NF-kappaB supersuppressor IkappaBalpha mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells. J Cell Biochem 2008; 105: 554-61.
16. Wang X, Ju W, Renouard J, Aden J, Belinsky SA, Lin Y. 17-allylamino- 17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factorkappaB pathway. Cancer Res 2006; 66: 1089-95. (Pubitemid 43165977)
17. Kastan MB, Canman CE, Leonard CJ. P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 1995; 14: 3-15.
18. Abdullaev FI. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L). Exp Biol Med (Maywood, NJ 2002; 227: 20-5.
19. Abdullaev FI. Inhibitory effect of crocetin on intracellular nucleic acid and protein synthesis in malignant cells. Toxicol Lett 1994; 70: 243-51.
20. Bathaie SZ, Bolhasani A, Hoshyar R, Ranjbar B, Sabouni F, Moosavi- Movahedi AA. Interaction of saffron carotenoids as anticancer compounds with ctDNA, Oligo (dG.dC)15, and Oligo (dA.dT)15. DNA Cell Biol 2007; 26: 533-40. (Pubitemid 47263199)
21. Kanakis CD, Tarantilis PA, Tajmir-Riahi HA, Polissiou MG. DNA interaction with saffron's secondary metabolites safranal, crocetin, and dimethylcrocetin. DNA Cell Biol 2007; 26: 63-70. (Pubitemid 46219593)
22. Kanakis CD, Tarantilis PA, Tajmir-Riahi HA, Polissiou MG. Interaction of tRNA with Safranal, Crocetin, and Dimethylcrocetin. J Biomol Struct Dyn 2007; 24: 537-46.
23. Hsu JD, Chou FP, Lee MJ, Chiang HC, Lin YL, Shiow SJ, et al. Suppression of the TPA-induced expression of nuclear-protooncogenes in mouse epidermis by crocetin via antioxidant activity. Anticancer Res
24. Magesh V, Singh JP, Selvendiran K, Ekambaram G, Sakthisekaran D. Antitumour activity of crocetin in accordance to tumor incidence, antioxidant status, drug metabolizing enzymes and histopathological studies. Mol Cell Biochem 2006; 287: 127-35.
25. Wesierska-Gadek J, Schloffer D, Kotala V, Horky M. Escape of p53 protein from E6-mediated degradation in HeLa cells after cisplatin therapy. Int J Cancer 2002; 101: 128-36. (Pubitemid 34970904)
26. Lee SJ, Ha MJ, Lee J, Nguyen P, Choi YH, Pirnia F, et al. Inhibition of the 3-hydroxy-3-methylglutaryl- coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21WAF1/CIP1 in human prostate carcinoma cells. J Biol Chem 1998; 273: 10618-23. (Pubitemid 28227674)
27. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, et al. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem 1997; 272: 22199-206. (Pubitemid 27382850)
28. Aikawa T, Segre GV, Lee K. Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2. J Biol Chem 2001; 276: 29347-52.
29. Kelman Z. PCNA: structure, functions and interactions. Oncogene 1997; 14: 629-40.